Therefore, serum AREG and HB-EGF levels could reflect different aspects of IIM pathophysiology, suggesting that a combination of these biomarkers could be a promising approach to understand the clinical characteristics of IIM. This evidence concerns the gene HBEGF and acquired idiopathic inflammatory myopathy.